DIVIS LABORATORIES
|
DIVIS LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
Equity - Authorised | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
Equity - Issued | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
Equity Paid Up | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹12,714 Cr | ₹11,675 Cr | ₹9,242 Cr | ₹7,257 Cr | ₹6,904 Cr |
Securities Premium | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹10,958 Cr | ₹9,989 Cr | ₹7,598 Cr | ₹5,794 Cr | ₹5,613 Cr |
General Reserves | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr |
Other Reserves | ₹676 Cr | ₹606 Cr | ₹564 Cr | ₹383 Cr | ₹211 Cr |
Reserve excluding Revaluation Reserve | ₹12,714 Cr | ₹11,675 Cr | ₹9,242 Cr | ₹7,257 Cr | ₹6,904 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹12,767 Cr | ₹11,728 Cr | ₹9,295 Cr | ₹7,310 Cr | ₹6,957 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹523 Cr | ₹407 Cr | ₹335 Cr | ₹270 Cr | ₹219 Cr |
Deferred Tax Assets | ₹30 Cr | ₹36 Cr | ₹16 Cr | ₹15 Cr | ₹14 Cr |
Deferred Tax Liability | ₹553 Cr | ₹443 Cr | ₹351 Cr | ₹284 Cr | ₹233 Cr |
Other Long Term Liabilities | ₹2.77 Cr | ₹2.87 Cr | ₹3.69 Cr | ₹4.47 Cr | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹31 Cr | ₹27 Cr | ₹25 Cr | ₹21 Cr | ₹773 Cr |
Total Non-Current Liabilities | ₹556 Cr | ₹437 Cr | ₹364 Cr | ₹295 Cr | ₹991 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹763 Cr | ₹796 Cr | ₹763 Cr | ₹591 Cr | ₹492 Cr |
Sundry Creditors | ₹763 Cr | ₹796 Cr | ₹763 Cr | ₹591 Cr | ₹492 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹331 Cr | ₹394 Cr | ₹340 Cr | ₹290 Cr | ₹244 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹33 Cr | ₹17 Cr | ₹16 Cr | ₹29 Cr | ₹29 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹299 Cr | ₹377 Cr | ₹324 Cr | ₹261 Cr | ₹215 Cr |
Short Term Borrowings | - | - | ₹0.35 Cr | ₹34 Cr | ₹106 Cr |
Secured ST Loans repayable on Demands | - | - | ₹0.35 Cr | ₹34 Cr | ₹106 Cr |
Working Capital Loans- Sec | - | - | ₹0.35 Cr | ₹34 Cr | ₹106 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | ₹-0.35 Cr | ₹-34 Cr | ₹-106 Cr |
Short Term Provisions | ₹439 Cr | ₹1,265 Cr | ₹624 Cr | ₹906 Cr | ₹5.30 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹434 Cr | ₹1,261 Cr | ₹622 Cr | ₹904 Cr | ₹4.19 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹4.92 Cr | ₹4.15 Cr | ₹2.51 Cr | ₹2.46 Cr | ₹1.11 Cr |
Total Current Liabilities | ₹1,533 Cr | ₹2,454 Cr | ₹1,728 Cr | ₹1,821 Cr | ₹847 Cr |
Total Liabilities | ₹14,857 Cr | ₹14,619 Cr | ₹11,387 Cr | ₹9,425 Cr | ₹8,795 Cr |
ASSETS | |||||
Gross Block | ₹6,365 Cr | ₹5,624 Cr | ₹4,692 Cr | ₹3,514 Cr | ₹2,634 Cr |
Less: Accumulated Depreciation | ₹1,642 Cr | ₹1,299 Cr | ₹988 Cr | ₹732 Cr | ₹546 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹4,723 Cr | ₹4,325 Cr | ₹3,704 Cr | ₹2,782 Cr | ₹2,088 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹212 Cr | ₹470 Cr | ₹711 Cr | ₹920 Cr | ₹492 Cr |
Non Current Investments | ₹77 Cr | ₹72 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹547 Cr |
Long Term Investment | ₹77 Cr | ₹72 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹547 Cr |
Quoted | - | - | - | - | ₹547 Cr |
Unquoted | ₹77 Cr | ₹72 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Long Term Loans & Advances | ₹98 Cr | ₹134 Cr | ₹173 Cr | ₹145 Cr | ₹1,013 Cr |
Other Non Current Assets | ₹3.65 Cr | ₹8.05 Cr | ₹9.21 Cr | ₹5.44 Cr | ₹5.36 Cr |
Total Non-Current Assets | ₹5,113 Cr | ₹5,009 Cr | ₹4,596 Cr | ₹3,851 Cr | ₹4,145 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | ₹971 Cr | ₹1,398 Cr |
Quoted | - | - | - | ₹971 Cr | ₹1,398 Cr |
Unquoted | - | - | - | - | - |
Inventories | ₹3,000 Cr | ₹2,829 Cr | ₹2,145 Cr | ₹1,864 Cr | ₹1,772 Cr |
Raw Materials | ₹972 Cr | ₹773 Cr | ₹706 Cr | ₹507 Cr | ₹520 Cr |
Work-in Progress | ₹1,526 Cr | ₹1,532 Cr | ₹1,093 Cr | ₹981 Cr | ₹928 Cr |
Finished Goods | ₹175 Cr | ₹154 Cr | ₹99 Cr | ₹64 Cr | ₹140 Cr |
Packing Materials | ₹9.36 Cr | ₹9.16 Cr | ₹8.38 Cr | ₹4.34 Cr | - |
Stores Ā and Spare | ₹192 Cr | ₹196 Cr | ₹104 Cr | ₹104 Cr | ₹111 Cr |
Other Inventory | ₹127 Cr | ₹165 Cr | ₹134 Cr | ₹203 Cr | ₹73 Cr |
Sundry Debtors | ₹1,793 Cr | ₹2,424 Cr | ₹1,677 Cr | ₹1,413 Cr | ₹1,163 Cr |
Debtors more than Six months | ₹10 Cr | ₹10 Cr | ₹14 Cr | - | - |
Debtors Others | ₹1,788 Cr | ₹2,419 Cr | ₹1,668 Cr | ₹1,427 Cr | ₹1,167 Cr |
Cash and Bank | ₹4,213 Cr | ₹2,819 Cr | ₹2,156 Cr | ₹123 Cr | ₹115 Cr |
Cash in hand | ₹0.92 Cr | ₹0.71 Cr | ₹0.75 Cr | ₹0.65 Cr | ₹0.61 Cr |
Balances at Bank | ₹4,212 Cr | ₹2,818 Cr | ₹2,155 Cr | ₹122 Cr | ₹115 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹29 Cr | ₹30 Cr | ₹52 Cr | ₹52 Cr | ₹12 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹27 Cr | ₹27 Cr | ₹23 Cr | ₹17 Cr | ₹9.19 Cr |
Other current_assets | ₹1.77 Cr | ₹2.60 Cr | ₹29 Cr | ₹35 Cr | ₹2.80 Cr |
Short Term Loans and Advances | ₹709 Cr | ₹1,509 Cr | ₹761 Cr | ₹1,150 Cr | ₹189 Cr |
Advances recoverable in cash or in kind | ₹34 Cr | ₹87 Cr | ₹31 Cr | ₹24 Cr | ₹59 Cr |
Advance income tax and TDS | ₹530 Cr | ₹1,317 Cr | ₹650 Cr | ₹973 Cr | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹145 Cr | ₹105 Cr | ₹80 Cr | ₹154 Cr | ₹130 Cr |
Total Current Assets | ₹9,744 Cr | ₹9,610 Cr | ₹6,791 Cr | ₹5,574 Cr | ₹4,650 Cr |
Net Current Assets (Including Current Investments) | ₹8,211 Cr | ₹7,156 Cr | ₹5,062 Cr | ₹3,753 Cr | ₹3,803 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹14,857 Cr | ₹14,619 Cr | ₹11,387 Cr | ₹9,425 Cr | ₹8,795 Cr |
Contingent Liabilities | ₹89 Cr | ₹89 Cr | ₹7.06 Cr | ₹7.71 Cr | ₹117 Cr |
Total Debt | - | - | ₹0.35 Cr | ₹34 Cr | ₹106 Cr |
Book Value | - | 441.82 | 350.15 | 275.38 | 262.09 |
Adjusted Book Value | 480.96 | 441.82 | 350.15 | 275.38 | 262.09 |
Compare Balance Sheet of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹98,695.6 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,015.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,809.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,408.7 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
MANKIND PHARMA | ₹96,037.1 Cr | NA | NA | NA | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,213.7 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -1.6% |
-7% |
23.8% |
SENSEX | -2.9% |
-0.4% |
20% |
You may also like the below Video Courses